These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34899694)

  • 1. Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species.
    Soto-Diaz K; Vailati-Riboni M; Louie AY; McKim DB; Gaskins HR; Johnson RW; Steelman AJ
    Front Immunol; 2021; 12():734349. PubMed ID: 34899694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates.
    Poulen G; Aloy E; Bringuier CM; Mestre-Francés N; Artus EVF; Cardoso M; Perez JC; Goze-Bac C; Boukhaddaoui H; Lonjon N; Gerber YN; Perrin FE
    Theranostics; 2021; 11(18):8640-8659. PubMed ID: 34522204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
    Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
    FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.
    Martínez-Muriana A; Mancuso R; Francos-Quijorna I; Olmos-Alonso A; Osta R; Perry VH; Navarro X; Gomez-Nicola D; López-Vales R
    Sci Rep; 2016 May; 6():25663. PubMed ID: 27174644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
    Conway JG; McDonald B; Parham J; Keith B; Rusnak DW; Shaw E; Jansen M; Lin P; Payne A; Crosby RM; Johnson JH; Frick L; Lin MH; Depee S; Tadepalli S; Votta B; James I; Fuller K; Chambers TJ; Kull FC; Chamberlain SD; Hutchins JT
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16078-83. PubMed ID: 16249345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF1R blockade slows progression of cerebral hemorrhage by reducing microglial proliferation and increasing infiltration of CD8 + CD122+ T cells into the brain.
    Cheng F; Wang C; Yan B; Yin Z; Liu Y; Zhang L; Li M; Liao P; Gao H; Jia Z; Li D; Liu Q; Lei P
    Int Immunopharmacol; 2024 May; 133():112071. PubMed ID: 38636374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
    Front Immunol; 2020; 11():579000. PubMed ID: 33162994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Behavioral Sequelae of Social Defeat Require Microglia and Are Driven by Oxidative Stress in Mice.
    Lehmann ML; Weigel TK; Poffenberger CN; Herkenham M
    J Neurosci; 2019 Jul; 39(28):5594-5605. PubMed ID: 31085604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF1R antagonism limits local restimulation of antiviral CD8
    Funk KE; Klein RS
    J Neuroinflammation; 2019 Jan; 16(1):22. PubMed ID: 30704498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma.
    Moon HG; Kim SJ; Lee MK; Kang H; Choi HS; Harijith A; Ren J; Natarajan V; Christman JW; Ackerman SJ; Park GY
    Allergy; 2020 Feb; 75(2):357-369. PubMed ID: 31385613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
    Liu Y; Given KS; Dickson EL; Owens GP; Macklin WB; Bennett JL
    Exp Neurol; 2019 Aug; 318():32-41. PubMed ID: 31029597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine.
    da Silva MCM; Gomes GF; de Barros Fernandes H; da Silva AM; Teixeira AL; Moreira FA; de Miranda AS; de Oliveira ACP
    Sci Rep; 2021 Aug; 11(1):15989. PubMed ID: 34362959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries.
    Pons V; Laflamme N; Préfontaine P; Rivest S
    Front Immunol; 2020; 11():47. PubMed ID: 32082318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment.
    Askew KE; Beverley J; Sigfridsson E; Szymkowiak S; Emelianova K; Dando O; Hardingham GE; Duncombe J; Hennessy E; Koudelka J; Samarasekera N; Salman RA; Smith C; Tavares AAS; Gomez-Nicola D; Kalaria RN; McColl BW; Horsburgh K
    Glia; 2024 Feb; 72(2):375-395. PubMed ID: 37909242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer.
    Moughon DL; He H; Schokrpur S; Jiang ZK; Yaqoob M; David J; Lin C; Iruela-Arispe ML; Dorigo O; Wu L
    Cancer Res; 2015 Nov; 75(22):4742-52. PubMed ID: 26471360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour.
    Rosin JM; Vora SR; Kurrasch DM
    Brain Behav Immun; 2018 Oct; 73():682-697. PubMed ID: 30056204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.